Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Clinical Outcomes of Patients with Newly Diagnosed Multiple Myeloma Receiving Triplet Therapy in the Connect MM ® Disease Registry

Jatin J. Shah, MD, Rafat Abonour, MD, Mohit Narang, Jayesh Mehta, Howard R. Terebelo, Cristina J Gasparetto, Kathleen Toomey, James W Hardin, Shankar Srinivasan, Gail Larkins, Yasir Nagarwala, Robert M. Rifkin

Blood (2015) 126 (23): 4229.

https://doi.org/10.1182/blood.V126.23.4229.4229

Published: 2015

Journal Articles

Investigating Efficacy, Safety, and Biomarkers in a Phase 2 Trial of Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) Following Second-Line Lenalidomide-Based Therapy (Tx) in Relapsed or Refractory Multiple Myeloma (RRMM)

David S Siegel, Gary Schiller, Kevin Song, Richy Agajanian, Keith Stockerl-Goldstein, Hakan Kaya, Michael Sebag, Frederic J Reu, Jorge Mouro, Michael Sturniolo, Shankar Srinivasan, Anjan Thakurta, Yasir Nagarwala, Nizar J Bahlis, MD

Blood (2015) 126 (23): 1853.

https://doi.org/10.1182/blood.V126.23.1853.1853

Published: 2015

Journal Articles

Patterns of Total Costs of Care over Time for Patients with Multiple Myeloma (MM)

Steven R Arikian, Gary Binder, Craig Gibson, X Henry Hu, Yasir Nagarwala, Mohamad A. Hussein, Frank A. Corvino, Jianyi Lee, Andy Surinach, Satyin Kaura, Saad Usmani

Blood (2015) 126 (23): 3294.

https://doi.org/10.1182/blood.V126.23.3294.3294

Published: 2015

Journal Articles

Connect MM ® —the Multiple Myeloma (MM) Disease Registry: Interim Analysis of Overall Survival and Outcomes in Patients with High-Risk Disease

Jatin J. Shah, MD, Rafat Abonour, MD, Brian G M Durie, MD, Jayesh Mehta, MD, Mohit Narang, MD, Howard Terebelo, DO, Cristina J Gasparetto, MD, Sachdev P. Thomas, MD, Kathleen Toomey, MD, James W Hardin, PhD, Shankar Srinivasan, PhD, Rosanna J. Ricafort, MD, Yasir Nagarwala, MD, Robert M. Rifkin, MD

Blood (2014) 124 (21): 2106.

https://doi.org/10.1182/blood.V124.21.2106.2106

Published: 2014

Journal Articles

Relationship Between Lenalidomide Dose Modification and Time to Next Treatment in Newly Diagnosed Multiple Myeloma Patients

Saad Z. Usmani, MD, Gary Binder, Dejan Milentijevic, X Henry Hu, Yasir Nagarwala, Frank A. Corvino, Steven R. Arikian, Andy Surinach, William N. Harwin

Blood (2014) 124 (21): 2655.

https://doi.org/10.1182/blood.V124.21.2655.2655

Published: 2014

Journal Articles

Patterns of Total Costs of Care for Newly Diagnosed Multiple Myeloma (MM) Patients

Steven R. Arikian, Dejan Milentijevic, Gary Binder, Mara Silvia Monzini, X Henry Hu, Yasir Nagarwala, Mohamad A. Hussein, MD, Frank A. Corvino, Andy Surinach, Saad Z. Usmani, MD

Blood (2014) 124 (21): 2656.

https://doi.org/10.1182/blood.V124.21.2656.2656

Published: 2014

Journal Articles

Components of Health Care Expenses Associated with Multiple Myeloma: An Analysis of US Claims Database

X Henry Hu, John Cai, Gary Binder, Mara Silvia Monzini, Yasir Nagarwala, MD

Blood (2014) 124 (21): 1318.

https://doi.org/10.1182/blood.V124.21.1318.1318

Published: 2014

Journal Articles

Connect MM®—the Multiple Myeloma (MM) Disease Registry: Incidence of Second Primary Malignancies (SPM)

Robert M. Rifkin, MD, Rafat Abonour, MD, Jatin J. Shah, MD, Jayesh Mehta, MD, Mohit Narang, MD, Howard R. Terebelo, DO, Cristina J Gasparetto, MD, Sachdev P. Thomas, MD, Kathleen Toomey, MD, James W Hardin, PhD, Jane Jie Lu, MS, Laurie Kenvin, BSN, RN, Shankar Srinivasan, PhD, Rosanna J. Ricafort, MD, Yasir Nagarwala, MD, Brian G. M. Durie, MD

Blood (2014) 124 (21): 4749.

https://doi.org/10.1182/blood.V124.21.4749.4749

Published: 2014

Journal Articles

Cost-Effectiveness Of Lenalidomide and Bortezomib In Patients With Previously Untreated Multiple Myeloma (MM)

Gerry Oster, PhD, Ariel Berger, MPH, Rebecca Bornheimer, BA, Gary Binder, MBA, Yasir Nagarwala, MD

Blood (2013) 122 (21): 5604.

https://doi.org/10.1182/blood.V122.21.5604.5604

Published: 2013

Journal Articles

Response To First-Line Treatment In Stem Cell Transplant (SCT) and Non-SCT Patients With Newly Diagnosed Multiple Myeloma Who Are Enrolled In The Connect MM Registry

Rafat Abonour, MD, Jatin J. Shah, M.D., Brian Durie, MD, Howard Terebelo, DO, Cristina J Gasparetto, MD, Jayesh Mehta, MD, Mohit Narang, MD, Sachdev P Thomas, MD, Kathleen Toomey, MD, Kristen A Sullivan, MBA, CCRA, Shankar Srinivasan, PhD, Yasir Nagarwala, MD, Robert M Rifkin, MD

Blood (2013) 122 (21): 3207.

https://doi.org/10.1182/blood.V122.21.3207.3207

Published: 2013

Journal Articles

Relationship Between Lenalidomide Dose Modification and Duration Of Treatment In Newly Diagnosed Multiple Myeloma Patients

Kathy Lang, PhD, Gary Binder, MBA, Iris Lin, PhD, Dejan Milentijevic, PhD, Huan Huang, PhD, Yasir Nagarwala, MD, William N. Harwin, MD

Blood (2013) 122 (21): 2944.

https://doi.org/10.1182/blood.V122.21.2944.2944

Published: 2013

NARROW

Clinical Outcomes of Patients with Newly Diagnosed Multiple Myeloma Receiving Triplet Therapy in the Connect MM ® Disease Registry

Investigating Efficacy, Safety, and Biomarkers in a Phase 2 Trial of Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) Following Second-Line Lenalidomide-Based Therapy (Tx) in Relapsed or Refractory Multiple Myeloma (RRMM)

Patterns of Total Costs of Care over Time for Patients with Multiple Myeloma (MM)

Connect MM ® —the Multiple Myeloma (MM) Disease Registry: Interim Analysis of Overall Survival and Outcomes in Patients with High-Risk Disease

Relationship Between Lenalidomide Dose Modification and Time to Next Treatment in Newly Diagnosed Multiple Myeloma Patients

Patterns of Total Costs of Care for Newly Diagnosed Multiple Myeloma (MM) Patients

Components of Health Care Expenses Associated with Multiple Myeloma: An Analysis of US Claims Database

Connect MM®—the Multiple Myeloma (MM) Disease Registry: Incidence of Second Primary Malignancies (SPM)

Cost-Effectiveness Of Lenalidomide and Bortezomib In Patients With Previously Untreated Multiple Myeloma (MM)

Response To First-Line Treatment In Stem Cell Transplant (SCT) and Non-SCT Patients With Newly Diagnosed Multiple Myeloma Who Are Enrolled In The Connect MM Registry

Relationship Between Lenalidomide Dose Modification and Duration Of Treatment In Newly Diagnosed Multiple Myeloma Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only